Priority Date: 12.07.12 (EP 20120176145)

METHOD AND KIT FOR PREDICTING OR MONITORING THE RESPONSE OF A CANCER PATIENT TO CHEMOTHERAPY, BASED ON MEASURING THE EXPRESSION LEVEL OF TMEM45A GENE.

  • Application ID: EP13727840
  • Status: EXAMINATION IN PROGRESS

Applicant

Research organisation logo small
Research Organisation

Attorney

Employment test 11 - 50 employees
Company dna pronovem
no operation time available
966.08
Headquarter in Brussels and 4 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 12.07.2012 - Priority Date (EP 20120176145)
  • 16.01.2014 - Publication A1 (WO2014009055)
  • 20.05.2015 - Publication A1 (EP2872645)

IPC Classification